Genesystem
진시스템 · 363250
Health Care Medical Devices · KOSDAQ
Market cap US$23M (₩31.7B)
Overview
Genesystem develops and makes molecular diagnostic tools, compact devices, biochips, test kits, and reagents that identify diseases by detecting genetic material, including at the point of care rather than in a central lab.
Its products are designed for ease of use, with reagents built directly into the biochip, and are aimed at clinical and diagnostic customers. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company generates a meaningful share of its revenue from exports. Its core platform supports a range of respiratory-disease test content, which it continues to expand for global distribution.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$650K
- FY2024US$875.2K
- FY2025US$276.3K
Operating profit
- FY2023−US$6.9M
- FY2024−US$7.3M
- FY2025−US$7M
Net income
- FY2023−US$5.8M
- FY2024−US$6.9M
- FY2025−US$10.6M
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?